HORROBIN DAVID F has a total of 24 patent applications. Its first patent ever was published in 1979. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are RESDEVCO RES AND DEV CO LTD, TRANSPHASE LTD and KULESZA JOHN E.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | South Africa | 3 | |
#5 | Finland | 2 | |
#6 | United Kingdom | 2 | |
#7 | Australia | 1 | |
#8 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Horrobin David Frederick | 14 |
#2 | Horrobin David F | 8 |
#3 | Lieb Julian | 5 |
#4 | Clarkson Sherri | 2 |
#5 | Ayton Agnes | 1 |
#6 | Begin Michel E | 1 |
#7 | Huang Y Sheng | 1 |
Publication | Filing date | Title |
---|---|---|
GB0216263D0 | Eicosapentaenoic acid and maintenance of hemodialysis shunt or graft | |
GB0214256D0 | Fatty acids and PPAR activators | |
WO0056404A1 | Formulations for treatment of pain comprising vitamin b12 and phenylanine | |
WO0051684A2 | Regulators of coenzyme-a-independent transacylase as psychotropic drugs | |
EP0085579A2 | Topical pharmaceutical compositions | |
US4386072A | Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor | |
US4328243A | Manic-depressive illnesses | |
US4248872A | Method for the treatment of anxiety | |
US4287202A | Treatment and/or prophylaxis of spasms of coronary arteries |